Literature DB >> 35585367

Anti-B cell strategy for complicated steroid-dependent nephrotic syndrome in children with antirituximab antibodies.

Shuichiro Fujinaga1, Shota Endo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35585367     DOI： 10.1007/s00467-022-05612-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.651


× No keyword cloud information.
  3 in total

1.  Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome.

Authors:  Shuichiro Fujinaga; Tomohiko Nishino; Shota Endo; Chisato Umeda; Yoshitaka Watanabe; Mayu Nakagawa
Journal:  Pediatr Nephrol       Date:  2020-06-16       Impact factor: 3.714

2.  Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial.

Authors:  Pietro Ravani; Manuela Colucci; Maurizio Bruschi; Marina Vivarelli; Michela Cioni; Armando DiDonato; Paolo Cravedi; Francesca Lugani; Francesca Antonini; Marco Prunotto; Francesco Emma; Andrea Angeletti; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2021-09-20       Impact factor: 14.978

3.  Anti-rituximab antibodies in pediatric steroid-dependent nephrotic syndrome.

Authors:  Quentin Bertrand; Sabine Mignot; Theresa Kwon; Anne Couderc; Anne Maisin; Alexandra Cambier; Véronique Baudouin; Marine Peyneau; Georges Deschênes; Julien Hogan; Claire Dossier
Journal:  Pediatr Nephrol       Date:  2021-06-16       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.